Dr. Min-Jeong Kim is Diagnomics’ Vice-President of Genomics and Molecular Medicine. He has supervised clinical laboratory operations under US CAP / CLIA regulation form over 8 years. He is well versed in molecular diagnostics, functional genomics, and molecular medicine. He has been overseeing the R&D laboratory at Diagnomics since 2017, after being the R&D director at our EONE-Diagnomics Genome Center (EDGC) in Incheon, Korea for over 2 years. Before, he served as the director of the Genomics facility at the Ohio University in Athens, OH. He obtained his PhD in Agricultural Biotechnology at the Seoul National University and his postdoctoral training at the Institute of Biological Chemistry at the Washington State University, WA. He published more than 10 scientific journal articles and is the author of several international patents.
SAN DIEGO, October 7, 2019 (Newswire.com) -Diagnomics Inc., a San Diego-based genetic testing company, is releasing a cardiovascular-focused genetic report…
Don't miss out the largest human genetics meeting in the world - ASHG 2019 in Houston! [About the ASHG…
Diagnomics, a leading genomics services provider, announced that it now has active CLIA certifications in three states: Maryland, Pennsylvania, and…
Diagnomics, a leading genetic testing company, has developed a new ACMG 59 report that is available to healthcare providers and…